Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2016: 3.273

CiteScore 2016: 3.01

SCImago Journal Rank (SJR) 2016: 1.679
Source Normalized Impact per Paper (SNIP) 2016: 0.800

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 383, Issue 1

Issues

Apolipoprotein(a): Structure-Function Relationship at the Lysine-Binding Site and Plasminogen Activator Cleavage Site

Eduardo Anglés-Cano / Gertrudis Rojas
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2002.009

Abstract

Apolipoprotein(a) [apo(a)] is the distinctive glycoprotein of lipoprotein Lp(a), which is disulfide linked to the apo B100 of a low density lipoprotein particle. Apo(a) possesses a high degree of sequence homology with plasminogen, the precursor of plasmin, a fibrinolytic and pericellular proteolytic enzyme. Apo(a) exists in several isoforms defined by a variable number of copies of plasminogenlike kringle 4 and single copies of kringle 5, and the protease region including the backbone positions for the catalytic triad (Ser, His, Asp). A lysinebinding site that is similar to that of plasminogen kringle 4 is present in apo(a) kringle IV type 10. These kringle motifs share some amino acid residues (Asp55, Asp57, Phe64, Tyr62, Trp72, Arg71) that are key components of their lysinebinding site. The spatial conformation and the function of this site in plasminogen kringle 4 and in apo(a) kringle IV-10 seem to be identical as indicated by (i) the ability of apo(a) to compete with plasminogen for binding to fibrin, and (ii) the neutralisation of the lysinebinding function of these kringles by a monoclonal antibody that recognises key components of the lysinebinding site. In contrast, the lysinebinding site of plasminogen kringle 1 contains a Tyr residue at positions 64 and 72 and is not recognised by this antibody. Plasminogen bound to fibrin is specifically recognised and cleaved by the tissuetype plasminogen activator at Arg561-Val562, and is thereby transformed into plasmin. A SerIle substitution at the activation cleavage site is present in apo(a). Reinstallation of the ArgVal peptide bond does not ensure cleavage of apo(a) by plasminogen activators. These data suggest that the stringent specificity of tissuetype plasminogen activator for plasminogen requires molecular interactions with structures located remotely from the activation disulfide loop. These structures ensure second site interactions that are most probably absent in apo(a).

About the article

Published Online: 2005-06-01

Published in Print: 2002-01-23


Citation Information: Biological Chemistry, Volume 383, Issue 1, Pages 93–99, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2002.009.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Corey A. Scipione, Marlys L. Koschinsky, and Michael B. Boffa
Critical Reviews in Clinical Laboratory Sciences, 2017, Page 1
[2]
Gianna Ferretti, Tiziana Bacchetti, Thomas P. Johnston, Maciej Banach, Matteo Pirro, and Amirhossein Sahebkar
Journal of Cellular Physiology, 2017
[3]
Toshihiko Hoashi, Jacqueline Muller, Wilfred D. Vieira, Francois Rouzaud, Kanako Kikuchi, Kunihiko Tamaki, and Vincent J. Hearing
Journal of Biological Chemistry, 2006, Volume 281, Number 30, Page 21198
[4]
Enzo Emanuele, Emmanouil Peros, Piercarlo Minoretti, Colomba Falcone, Angela D'Angelo, Lorenza Montagna, and Diego Geroldi
BMC Cardiovascular Disorders, 2003, Volume 3, Number 1
[5]
Rainer Vormittag, Thomas Vukovich, Milena Stain, Stephan Lehr, Erich Minar, and Ingrid Pabinger
Thrombosis Research, 2007, Volume 120, Number 1, Page 15
[6]
Won Chan Choi, Min Young Kim, Chang Woo Suh, and Eun Kyu Lee
Process Biochemistry, 2005, Volume 40, Number 5, Page 1967
[7]
Hong‐Xia Zhang, Lei Fang, Jian Cheng, Zheng Wei, and Zi‐Chun Hua
Preparative Biochemistry and Biotechnology, 2005, Volume 35, Number 1, Page 17
[8]
Ming Zhu, Jian Cheng, and Zi-Chun Hua
Preparative Biochemistry and Biotechnology, 2003, Volume 33, Number 4, Page 269
[9]
Christos S Katsouras, Loukas D Tsironis, Moses Elisaf, John A Goodevenos, Lampros K Michalis, and Alexandros D Tselepis
Future Cardiology, 2005, Volume 1, Number 4, Page 509
[10]
Martin Hermel, Wendelin Dailey, Michael Trese, and Michael K. Hartzer
Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, Volume 249, Number 1, Page 37
[11]
Enzo Emanuele, Emmanouil Peros, Carmine Tomaino, Enrica Feudatari, Livia Bernardi, Giuliano Binetti, Raffaele Maletta, Giuseppe Micieli, Amalia C. Bruni, and Diego Geroldi
Dementia and Geriatric Cognitive Disorders, 2004, Volume 18, Number 2, Page 189

Comments (0)

Please log in or register to comment.
Log in